Literature DB >> 18602392

Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries.

Yaru Dong1, Hiroshi Watabe, Guanfang Su, Hitoshi Ishikawa, Noriko Sato, Takeshi Yoshitomi.   

Abstract

Our objective was to determine if tafluprost, a newly synthesized antiglaucoma drug, can relax precontracted rabbit ciliary arteries, and if so, to elucidate the underlying mechanism. We used isometric tension recordings of smooth muscle contractions and fluorescence photometry to monitor the change of intracellular free calcium concentration ([Ca(2+)](i)) in isolated rabbit ciliary artery segments. Tafluprost induced a concentration-dependent relaxation in rabbit ciliary arteries precontracted with a high-K solution. The amplitude of relaxation induced by tafluprost was unchanged by 100 microM L-NAME, 10 microM indomethacin, denudation of vascular endothelium, 30 microM thapsigargin, or 100 microM ouabain. In Ca(2+)-free solution, 30 microM tafluprost did not decrease the amplitude of contraction induced by 1 microM histamine or the amplitude of the [Ca(2+)](i) increase induced by 10 microM histamine. The mechanism of tafluprost-induced relaxation was different from diltiazem, a voltage-dependent Ca(2+) channel blocker. However, in thapsigargin-pretreated preparations incubated in Ca(2+)-free solution, tafluprost attenuated the capacitative increase of [Ca(2+)](i) upon Ca(2+) reintroduction to the extracellular medium. Thus, we conclude that tafluprost relaxed isolated rabbit ciliary artery segments precontracted with a high-K solution. The relaxing mechanism was not dependent on endothelial-derived factors, and not affected by the intracellular Ca(2+) cycles or the Ca(2+) extrusion component of the extracellular Ca(2+) cycles. Relaxation of rabbit ciliary artery smooth muscle by tafluprost may be due, at least in part, to inhibition of capacitative Ca(2+) entry from the extracellular space.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602392     DOI: 10.1016/j.exer.2008.06.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

1.  Dorzolamide-induced relaxation of isolated rabbit ciliary arteries mediated by inhibition of extracellular calcium influx.

Authors:  Yaru Dong; Yu Sawada; Jizhe Cui; Masahiro Hayakawa; Dai Ogino; Makoto Ishikawa; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2016-01-12       Impact factor: 2.447

2.  Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.

Authors:  Hiroshi Watabe; Sanae Abe; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2011-06-11       Impact factor: 2.447

3.  Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.

Authors:  Yusuke Ohta; Sanae Takaseki; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2017-06-26       Impact factor: 2.447

Review 4.  Effects of Tafluprost on Ocular Blood Flow.

Authors:  Xinyue Zhang; Xiaoyu Zhou; Yang Zhao; Xiang Yang; Dengming Zhou; Baihua Chen; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-09-15

5.  Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension.

Authors:  Makoto Aihara
Journal:  Clin Ophthalmol       Date:  2010-03-24

6.  Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.

Authors:  Dorota Pozarowska
Journal:  Clin Ophthalmol       Date:  2010-10-21

7.  Effects of brinzolamide on rabbit ocular blood flow in vivo and ex vivo.

Authors:  Ya-Ru Dong; Shi-Wei Huang; Ji-Zhe Cui; Takeshi Yoshitomi
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

8.  Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma.

Authors:  Yang Liu; Weiming Mao
Journal:  Clin Ophthalmol       Date:  2012-12-21

9.  Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye.

Authors:  Naoko Aizawa; Hiroshi Kunikata; Yukihiro Shiga; Satoru Tsuda; Yu Yokoyama; Kazuko Omodaka; Tomoki Yasui; Keiichi Kato; Hiroaki Kurashima; Etsuyo Miyamoto; Masayo Hashimoto; Toru Nakazawa
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

10.  Tafluprost for the reduction of interocular pressure in open angle glaucoma and ocular hypertension.

Authors:  Clyde Schultz
Journal:  Ophthalmol Eye Dis       Date:  2011-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.